Advertisement

Topics

Gelesis Granted FDA Clearance to Market Plenity - a New Prescription Aid in Weight Management

19:04 EDT 14 Apr 2019 | Drugs.com

BOSTON, April 14, 2019 — Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, today announced that the United States Food and Drug...

Original Article: Gelesis Granted FDA Clearance to Market Plenity - a New Prescription Aid in Weight Management

NEXT ARTICLE

More From BioPortfolio on "Gelesis Granted FDA Clearance to Market Plenity - a New Prescription Aid in Weight Management"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...